BSE filing, NSE: MAYUKH. Summary written from the filing by ALFA Finder's alert engine.
Sattva Sukun Lifecare Ltd: key numbers
- Share price
- ₹1.16
- Market cap
- ₹44.50 Cr
- Revenue (annual)
- ₹32.25 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- -91.9×Sector 45.2×
- Promoter holding
- 3.65%-2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sattva Sukun Lifecare Ltd
All →Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, in compliance with SEBI regulations.
Sattva Sukun Lifecare Acquisition Worth ₹67.19 Cr
Tavexia Lifecare will acquire a 60% stake in Meyonex Pharmaceuticals Limited for ₹67.19 Crore. This strategic investment aims to expand its pharmaceutical sector presence.
- Value
- ₹67.19 Cr
Sattva Sukun Lifecare Annual General Meeting
Tavexia Lifecare Limited concluded its 46th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, auditor appointment, related party transactions, and director re-appointment.
Sattva Sukun Lifecare Promoter Selling: ₹0.03 Cr
Promoter group entity Roshan Dealmark Private Limited sold 2,50,000 equity shares of Tavexia Lifecare Ltd via market sale.
- Value
- ₹0.03 Cr
- Promoter stake change
- -0.04%
Sattva Sukun Lifecare Board Meeting Date
Tavexia Lifecare will hold a board meeting on October 7, 2026, to discuss the proposed acquisition of Meyonex Pharmaceuticals and approve the half-yearly financial results.
Sattva Sukun Lifecare Promoter Selling: ₹0.08 Cr
Roshan Dealmark Private Limited (Promoter Group) sold 700,000 equity shares of Tavexia Lifecare Ltd via market sale on September 25, 2026.
- Value
- ₹0.08 Cr
- Promoter stake change
- -0.18%
Other board meeting date announcements
All →Fundviser Capital (India) Board Meeting Date
Fundviser Capital (India) Ltd intimated a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are announced.
Dhanlaxmi Cotex Board Meeting Date
Dhanlaxmi Cotex will hold a board meeting on November 12, 2026 to approve unaudited standalone results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results are announced.
Monika Alcobev Board Meeting Date
Monika Alcobev Ltd will hold a board meeting on November 6, 2026 to approve unaudited half-year results ended September 30, 2026. The trading window reopens 48 hours after results declaration.
Dhunseri Tea & Industries Board Meeting Date
Dhunseri Tea & Industries will hold its 131st board meeting on 6 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are made public.
Eastcoast Steel Board Meeting Date
Eastcoast Steel will hold a board meeting on 6 November 2026 to consider standalone unaudited results for the quarter and half year ended 30 September 2026. The notice also confirms the trading window closure from 1 October 2026.
Shree Hari Chemicals Export Board Meeting Date
Shree Hari Chemicals will meet on 6 November 2026 to consider unaudited September 2026 quarter and half-year results. Trading window reopens 9 November 2026.